The Global Alzheimer's Initiative Now Act authorizes the United States to participate in and contribute funds to the Davos Alzheimer's Collaborative (DAC), an international public-private partnership aimed at preventing, diagnosing, and treating Alzheimer's disease and dementia worldwide. The bill establishes that U.S. contributions must be matched by funding from other sources and cannot exceed 33 percent of DAC's total funding during fiscal years 2026 through 2030, ensuring shared responsibility among participating nations. The legislation requires the President to designate a federal representative to serve on DAC's governing bodies and to submit annual reports to Congress detailing U.S. financial contributions, governance participation, and how the initiative supports American global health and Alzheimer's research goals. The bill addresses the urgent global health challenge of Alzheimer's disease, which currently affects 60 million people worldwide and is projected to reach 150 million by 2050, with low- and middle-income countries bearing the heaviest burden.
Take Action
Your position
Add a comment
to comment on this bill.
Annotate the text
Highlight any passage on the Summary or Full Text tab to attach a note. Annotations appear on the Annotations tab.